2.1
Olaparib (Lynparza, AstraZeneca) with abiraterone and prednisone or prednisolone is indicated for 'the treatment of adult patients with metastatic castration-resistant prostate cancer in whom chemotherapy is not clinically indicated'.
2 Information about olaparib with abiraterone
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for olaparib.
Price
2.3
The list price for olaparib is £2,317.50 per pack of 56 tablets, each containing 100 mg or 150 mg of the active ingredient (excluding VAT; BNF online, accessed December 2023). The list price for abiraterone is £2,735 for a pack of 56 x 500 mg tablets (excluding VAT; BNF online, accessed December 2023).
2.4
The company has a commercial arrangement. This makes olaparib with abiraterone available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.